Nautilus

Big Data Helps Find the Achilles Heel of Each Individual Cancer

In January, the pharmaceutical company Roche paid more than a billion dollars to buy about half of a small company called Foundation Medicine. Foundation has not invented any new drugs or life-saving devices. Most insurance companies won’t pay for its main product, and like a lot of biotech companies, it loses money.

The big bucks are for Foundation’s information. Roche, Foundation, and many other cancer researchers now believe that thinking about cancer in terms of data is going to be the way to beat the disease. The deal gives Roche access to Foundation’s database, which holds the DNA sequences of the tumors of 35,000 cancer patients, along with information about what kinds of drugs they were treated with and how good

You’re reading a preview, subscribe to read more.

More from Nautilus

Nautilus10 min read
The Ocean Apocalypse Is Upon Us, Maybe
From our small, terrestrial vantage points, we sometimes struggle to imagine the ocean’s impact on our lives. We often think of the ocean as a flat expanse of blue, with currents as orderly, if sinuous, lines. In reality, it is vaster and more chaoti
Nautilus7 min read
Lithium, the Elemental Rebel
Inside every rechargeable battery—in electric cars and phones and robot vacuums—lurks a cosmic mystery. The lithium that we use to power much of our lives these days is so common as to seem almost prosaic. But this element turns out to be a wild card
Nautilus13 min read
The Shark Whisperer
In the 1970s, when a young filmmaker named Steven Spielberg was researching a new movie based on a novel about sharks, he returned to his alma mater, California State University Long Beach. The lab at Cal State Long Beach was one of the first places

Related Books & Audiobooks